Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Elevated Lymphocytes Predict Survival Outcomes in Early Breast Cancer
1
Mins
July 2024
Synergistic Immune-Mediated Anti-tumour Effect of Dostarlimab and Radiotherapy in the Management of MSI-H/dMMR Endometrial Cancer: A Case Report.
Read more
1
Mins
22nd May 2018
6-Month Course of Herceptin Just as Effective as 12 Months in Breast Cancer Treatment
Herceptin treatment for women with HER2-positive early-stage breast cancer is just as effective when taken for 6 months in preventing relapse and death…
1
Mins
15th May 2018
Oral Drug Can Prevent Recurrence of Venous Thromboembolism in Cancer Patients
Cancer patients can be protected from further recurrence of venous thromboembolism (VTE) with an oral drug, suggests results of a study from the…
1
Mins
25th April 2018
Machine Modelling Technique Enables Greater Confidence in Assessing Cancer Treatments
Efficacy of cancer treatments could be more effectively measured using an adaptation of a machine learning approach originally designed to help…
1
Mins
20th April 2018
New Discovery Could Help Overcome Chemoresistance in a Form of Breast Cancer
Improved care for triple-negative breast cancer (TNBC) could take place following the discovery that the condition is chemoresistant even before…
1
Mins
19th April 2018
Engineered T Cells Shown to Eliminate Paediatric Brain Cancer
Elimination of a paediatric brain tumour called diffuse intrinsic pontine glioma (DIPG) has successfully taken place in a mouse model through the…
1
Mins
17th April 2018
Trial Results Lead to Calls for all Advanced NSCLC Patients to Receive Immunotherapy
All patients with advanced non-small-cell lung cancer (NSCLC) should receive immunotherapy according to Prof Solange Peters, ESMO President Elect…
2
Mins
12th April 2018
Cancer Genetic Mutations Not All Treatable: System to Rank Relevance of Mutations Needed
ESMO, the leading professional organisation for medical oncology, welcomes the latest reports from The Cancer Genome Atlas (TCGA) as a major…
1
Mins
6th April 2018
Discovery of Mutations that are Functional in Cancer Could Provide New Treatment Targets
Potential new targets for cancer treatments have been identified following the discovery of nearly 200 mutations in non-coding DNA that have a functional…
Loading posts...
« Previous
1
…
12
13
14
15
16
…
32
Next »